Literature DB >> 17638653

Significance of lymphatic invasion and proliferation on regional lymph node metastasis in renal cell carcinoma.

Yukio Ishikawa1, Shinsuke Aida, Seiichi Tamai, Yoshikiyo Akasaka, Hideko Kiguchi, Yuri Akishima-Fukasawa, Masamichi Hayakawa, Shigehiro Soh, Kinji Ito, Masayo Kimura-Matsumoto, Shigeki Ishiguro, Chiaki Nishimura, Itaru Kamata, Reiko Shimokawa, Toshiharu Ishii.   

Abstract

We studied the associations of lymphatic invasion and lymphatic vessel density around tumors with lymph node (LN) status in renal cell carcinoma (RCC) by immunohistochemical analysis using D2-40 antibody as a lymphatic marker. Surgically removed specimens from 76 cases with RCC, including 16 cases with LN metastasis, were used. Lymphatic vessel density around the tumor increased compared with normal kidneys but was not significant by LN status. Tumor size, tumor cell types, patterns of tumor growth, nuclear grade of tumor cells, venous invasion, lymphatic invasion, and primary tumor stage were predictive factors for LN metastasis. Based on multivariate regression analysis, only lymphatic invasion was an independent risk factor for LN metastasis. The immunohistochemical detection of lymphatics was useful for identifying the lymphatic invasion of RCC, and the presence of lymphatic invasion around RCC was an independent predictive factor for LN metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638653     DOI: 10.1309/0FT8WTDKREFHHP4P

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer.

Authors:  Costanza Chiapponi; Hakan Alakus; Matthias Schmidt; Michael Faust; Christiane J Bruns; Reinhard Büttner; Marie-Lisa Eich; Anne M Schultheis
Journal:  Front Med (Lausanne)       Date:  2022-02-21

2.  A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma.

Authors:  Wenle Li; Bing Wang; Shengtao Dong; Chan Xu; Yang Song; Ximin Qiao; Xiaofeng Xu; Meijin Huang; Chengliang Yin
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.